Også for den kombinerede NSAID- gruppe var der ingen statistisk signifikant forskel for komplicerede mavesår (relativ risiko 0, 77, 95%, CI 0, 41 - 1, 46, set over hele studieperioden).
Also for the combined NSAID group there was no statically significant difference for complicated ulcers (relative risk 0,77, 95% CI 0.41-1.46, based on entire study duration).